Meeting Thu, 07/20/2023 - 12:00 Drug Utilization Review Board Meeting Information

Date
Media
Edit Implementation Schedule July 2023
New Drugs and Edits with no annual changes
PDL Announcement 07-20-23
PDL Recommendations 07-20-23
Conduent Reports July 2023
MO Pharmacy Advisory Board Slides July 2023
Agenda
Agenda 7-20-23
Minutes
DUR Minutes July 2023 Approved
Criteria
DUR Criteria
Clinical Edit Proposals – Existing Criteria
Media
AMPYRA July 2023
Besremi July 2023
C5 Complement Inhibitors July 2023
CAR-T Cell July 2023
Crysvita July 2023
DMD July 2023
Gamifant July 2023
Iron – Injectable July 2023
Koselugo July 2023
Luxturna July 2023
NMOSD July 2023
Reblozyl July 2023
TIMS, Small Molecule JAK Inhibitor July 2023
Tolvaptan July 2023
Vyvgart July 2023
Zometa July 2023
DUR Criteria
Clinical Edit Proposals – New or Revised Criteria
Media
DAYBUE July 2023
Enjaymo July 2023
Filspari July 2023
Givlaari July 2023
Joenja July 2023
Synagis July 2023
Tepezza July 2023
DUR Criteria
Preferred Drug List Edit Proposals – Existing Criteria
Media
Alpha Glucosidase Inhibitors July 2023
Amylin Analogs July 2023
Biguanides & Combination Agents July 2023
Cryopyrin-Associated Periodic Syndrome (CAPS) July 2023
DPPIV Inhibitors July 2023
Erythropoiesis Stimulating Agents July 2023
GLP-1s and Combination Agents July 2023
Insulin, Mixed July 2023
Insulin, Non-Analogs July 2023
Insulin, Rapid Acting July 2023
LHRH, GnRH Agents, Oral July 2023
Meglitinides July 2023
Methotrexate Agents July 2023
Psoriasis Agents, Oral July 2023
Sulfonylurea Agents, 2nd Generation July 2023
Thiazolidinediones & Combos July 2023
TIMs, IL17 Receptor Antagonists July 2023
TIMs, IL23-12 Inhibitors July 2023
DUR Criteria
Preferred Drug List Edit Proposals – New or Revised Criteria
Media
Atopic Dermatitis Agents, Immunomodulators July 2023
Bleeding Disorder Agents July 2023
Colony Stimulating Factors July 2023
Growth Hormone Agents, Somatropin July 2023
Growth Hormone Releasing Factors, Select Agents July 2023
Insulin, Long Acting July 2023
LHRH, GnRH Agents, Non-Oral July 2023
Multiple Sclerosis Agents, Injectable July 2023
Multiple Sclerosis Agents, Oral July 2023
Psoriasis Agents, Topical July 2023
SGLT Inhibitors July 2023
Thrombocytopenia Agents July 2023
TIMs, IL6 Receptor Inhibitors July 2023
TIMs, JAK Inhibitors July 2023
TIMs, Misc Allergy & Asthma Related Monoclonal Antibodies July 2023
TIMs, Select Agents July 2023
TIMs, Select Agents July 2023
Urinary Tract Antispasmodics July 2023
Page
Drug Utilization Review Board Meeting Information